Brain Cancer

BRAIN CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Eponyms in Oncology: Li-Fraumeni Syndrome

This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Li-Fraumeni syndrome.
PTSD in Cancer Patients: What Providers Need to Know

Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes.
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse

More than one-third of tumors sequenced carried a high mutation burden.
How to Prevent a Cyberattack from Derailing Cancer Care

Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Changes in Clinical Trial Conduct Prompted by the COVID-19 Pandemic Should Persist

The AACR COVID-19 and Cancer Task Force recommends keeping changes to clinical trial practices that were prompted by the pandemic.

BRAIN CANCER NEWS

Man receiving radiotherapy for cancer

ASTRO Offers Guidance on RT for IDH-Mutant Diffuse Grade 2, 3 Glioma

September 21, 2022

Retifanlimab, HFRT, and Bevacizumab Produce “Encouraging” Results in Recurrent Glioblastoma

September 19, 2022

A clinician observes the results of a genetic test on a tablet

Pathogenic Variants in BRCA1/2, MMR Genes Linked to Pediatric Cancer

September 1, 2022

Doctor talking to couple in waiting room

Depatuxizumab Mafodotin Does Not Improve Overall Survival in Glioblastoma

July 28, 2022

Diagnosis With Late-Stage Cancer More Likely Without Private Insurance

July 15, 2022

Next post in Brain Cancer

Blood Biomarkers May Help ID Primary CNS Lymphoma, High-Grade Glioma